Treatment of bronchiectasis based on the theory of "pathogen hiding in lung collaterals"
Clinical Studies|更新时间:2023-07-05
|
Treatment of bronchiectasis based on the theory of "pathogen hiding in lung collaterals"
Journal of Beijing University of Traditional Chinese MedicineVol. 46, Issue 6, Pages: 853-858(2023)
作者机构:
1.广州中医药大学 广州 510006
2.苏州市中西医结合医院
3.珠海市中西医结合医院
4.北京大学人民医院
5.广东省中医院珠海医院
作者简介:
HUANG Donghui, Chief Physician, Doctoral Supervisor. Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, No.208, Yuehua Road, Xiangzhou District, Zhuhai 519000. E-mail: 13600001163@139.com
基金信息:
National Natural Science Foundation of China(82074345);Research project of Guangdong Provincial Bureau of Traditional Chinese Medicine(20221362)
ZHAI Ting, WANG Pan, WANG Yuan, et al. Treatment of bronchiectasis based on the theory of "pathogen hiding in lung collaterals"[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(6): 853-858.
DOI:
ZHAI Ting, WANG Pan, WANG Yuan, et al. Treatment of bronchiectasis based on the theory of "pathogen hiding in lung collaterals"[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(6): 853-858. DOI: 10.3969/j.issn.1006-2157.2023.06.017.
Treatment of bronchiectasis based on the theory of "pathogen hiding in lung collaterals"
Bronchiectasis is characterized by recurrent airway infections
a progressive inflammatory response
and persistent decline in lung function. Airway remodeling is the key to its pathology. It is of great significance to explain the dynamic evolution of airway remodeling in patients with bronchiectasis using the theory of "latent pathogen" and "chronic diseases affecting the collaterals"
which are essential pathogenesis theories of traditional Chinese medicine. Lung collaterals are small and microscopic
and they allow the flow of qi and blood to infiltrate and nourish the lungs. Phlegm
blood stasis
heat
and other latent pathogens can hide deep and distantly
causing self-accumulation and aggregation
time-delayed attacks
and long-term affecting the collaterals. The process by which the functional structure of the lung collaterals is changed due to the accumulation of evil qi is closely related to the process of chronic inflammation caused by bacterial colonization in bronchiectasis. Based on the above
our team believed that the pathogenesis of the acute stage of bronchiectasis is triggered by external factors
the internal hidden pathogens are activated
phlegm and fire mutually cause immediate qi activity
and the latent pathogens accumulate to damage the lung collaterals. The pathogenesis in the stable stage differs
in that the latent pathogens move inward
and the lung collaterals are damaged after prolonged disease
with lung deficiency and collateral stasis. Furthermore
pathogens from masses in collaterals due to long-term retention
and "pathogenic qi in the lung collaterals" is the core of the pathogenesis of bronchiectasis
and latent phlegm is present through the entire course of the disease. The clinical treatment of our team is based on the syndrome differentiation and treatment of "dredging collaterals to make it work"
which is mainly treated with a pungent drug. In the acute phase
pungent drugs should be used to dredge collaterals
clear collaterals
and remove pathogens
while the patient in the stable period should be treated by a tonifying deficiency
dredging collaterals
and supporting the healthy qi to dispel the pathogen. This approach provide new ideas for guiding clinical treatment.